<DOC>
	<DOCNO>NCT00677716</DOCNO>
	<brief_summary>Cotara® experimental new treatment link radioactive isotope ( iodine 131 ) target monoclonal antibody . This monoclonal antibody design bind tumor cell deliver radiation directly center tumor mass minimize effect normal tissue . Cotara® thus literally destroy tumor `` inside '' . This may effective treatment glioblastoma multiforme , malignant type brain cancer .</brief_summary>
	<brief_title>Dose Confirmation Study Cotara Treatment Glioblastoma Multiforme First Relapse</brief_title>
	<detailed_description>To confirm safety tolerability Maximum Tolerated Dose ( MTD ) 131I-chTNT-1/B MAb give single interstitial infusion patient glioblastoma multiforme first relapse . To estimate overall survival , progression free survival proportion patient alive six month treatment .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Histologically confirm GBM Clinical Target Volume 5 60 cc ( inclusive ) 18 75 year old ( inclusive ) Karnofsky Performance Status ≥ 70 percent If steroid dose ( ± 4mg/day ) must stable least two week prior screening/baseline visit . If steroid two week prior screening/baseline visit allow Adequate hematology Adequate renal function Adequate liver function Infratentorial tumor ( ) , tumor ( ) communicate ventricle intraventricular disease Bilateral noncontiguous gadolinium enhance tumor Diffuse disease ( i.e. , satellite lesion less 1.5 cm anticipate location catheter tip less two satellite lesion ) Known suspect allergy study medication iodine Surgical procedure within four week baseline More one prior chemotherapy regime chemotherapy within four week ( nitrosoureabased within six week ) baseline Radiation therapy within four week baseline Investigational agent within last 30 day Previous treatment chimeric monoclonal antibody HIV positive Evidence active hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>glioblastoma multiforme</keyword>
	<keyword>GBM</keyword>
	<keyword>brain cancer</keyword>
	<keyword>Cotara</keyword>
	<keyword>radioactive isotope</keyword>
	<keyword>monoclonal antibody</keyword>
	<keyword>Glioblastoma multiforme first relapse</keyword>
</DOC>